PR Newswire Asia's news > Biotechnology

 < Previous page   |   Title only   |   Print    Next page > 
     
3SBio Announces 2025 Annual Results: Dual Engines of Innovative R&D and Global Collaboration Propel Revenue Past RMB 10 Billion Milestone
SHANGHAI , March 31, 2026 /PRNewswire/ -- 3SBio Inc. ( 01530.HK ) today released its 2025 annual results announcement. Fueled by the dual core engines of breakthroughs in innovative R&D and strategic ...
2026-03-31T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD
TAMPA, Fla. , March 31, 2026 /PRNewswire/ -- Concept Medical Inc. (CMI), a global leader in innovative drug-delivery technology across vascular interventions, proudly announces the presentation of ...
2026-03-31T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
DNV SELECTED TO CERTIFY CLASS D DEVICES FOR LEADING U.S. MANUFACTURER UNDER EU IVDR
DNV supports the manufacturer's transition to new regulation with its digital certification platform and transparent, predictable project management. ...
2026-03-31T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical Equipment 
Abbisko Therapeutics' FGFR2/3 Inhibitor ABSK061 Receives FDA IND Clearance for Achondroplasia in Children
SHANGHAI , March 31, 2026 /PRNewswire/ -- On 30 March, 2026 , Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) announced that the U.S. Food and ...
2026-03-31T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
NAVER D2SF Makes Follow-On Investment in Nuvilab, AI Nutrition Analytics Startup
SEONGNAM, South Korea , March 31, 2026 /PRNewswire/ -- NAVER D2SF, the corporate venture capital arm of NAVER, has made a follow-on investment in Nuvilab, an AI-powered nutrition analytics healthcare startup. ...
2026-03-31T    Biotechnology   Computer/Electronics   Food/Beverages   Health Care/Hospital 
Sanyou Milestone | Recognized as a "Shanghai Municipal Enterprise Technology Center," Further Validating for Innovation Excellence
SHANGHAI , March 30, 2026 /PRNewswire/ -- Sanyou Biopharmaceuticals has recently been honored as a "Shanghai Municipal Enterprise Technology Center" in recognition of its outstanding technological ...
2026-03-30T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
Harbour BioMed Reports Full Year 2025 Financial Results: Sustained Global Collaboration Underpins Long-Term Growth
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , March 30, 2026 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company ...
2026-03-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
NYSE Content Update: Koppers to Ring Closing Bell for 20th Listing Anniversary
NYSE issues a pre-market daily advisory direct from the trading floor. ...
2026-03-30T    Agriculture   Banking/Financial Service   Biotechnology 
Tigermed Announces 2025 Annual Results
HANGZHOU, China , March 30, 2026 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading global provider ...
2026-03-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
CGBIO Showcases Minimally Invasive Spine Surgery Techniques in Thailand: "Smaller Incisions, Faster Recovery"
Korea–Thailand spine experts jointly lead advanced training on endoscopic spine surgery and lateral lumbar interbody fusion techniques Hands-on experience with Korean spine medical devices lays the ...
2026-03-30T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.